1-(2-Chlorophenyl)piperazine → 3-{5-[4-(2-chlorophenyl)-piperazin-1-yl]-pentyl}-3-ethyl-1,3-dihydro-2H-indol-2-one monohydro-chloride
반응식
Br[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][C:7]1([CH2:17][CH3:18])[C:15]2[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=2)[NH:9][C:8]1=[O:16].[Cl:19][C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[N:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1>>[ClH:19].[Cl:19][C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[N:26]1[CH2:31][CH2:30][N:29]([CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][C:7]2([CH2:17][CH3:18])[C:15]3[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=3)[NH:9][C:8]2=[O:16])[CH2:28][CH2:27]1참가 물질
3
실험 절차
The title compound is prepared according to process H by applying processing method 2 starting from 3-(5-bromopentyl)-3-ethyl-1,3-dihydro-2H-indol-2-one and 1-(2-chlorophenyl)-piperazine.
출처 및 근거
- ORD 기록
- ord-a819048e7e7849dabbf75df884a3120b
- 출처 데이터셋
- uspto-grants-2010_08
- 특허 번호
- US07786129B2
반응 노트
불러오는 중…